We are L-Arginine Monohydrochloride CAS:1119-34-2 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
A monohydrochloride salt of L-arginine. L-Arginine is a substrate of nitric oxide synthase, which is converted to L-citrulline and nitric oxide (NO). It is widely used as an ingredient in infusion and infant formula.
|Specification||White crystals or crystalline powder, odorless, slightly characteristic taste|
|Applications||Infusion, Cell culture media, Biotech|
|STORAGE||Controlled room temperature in tight container|
SPECIFICATION AND PROCEDURE
| State of solution
|Not Less Than 98.0%|
|Ammonium (NH4)||Not More Than 0.020%|
|Chloride content (Cl)||16.6～17.0%|
|Sulfate (SO4)||Not More Than 0.020%|
|Iron (Fe)||Not More Than 10 ppm|
|Heavy metals (Pb)**||Not More Than 10 ppm|
|Arsenic (As2O3)||Not More Than 1 ppm|
|Loss on drying||Not More Than 0.20%|
|Residue on ignition||Not More Than 0.10%|
|Related substances||Not More Than 0.4%|
|Endotoxin*||Less Than 6.0 EU/g|
|Assay (dry basis)||99.0～101.0%|
· * The endotoxin-certified grade will be supplied on request.
· ** FCC grade (Lead : Not More Than 5 mg/kg) will be supplied on request.
· This product meets requirements of residual solvents listed in the current JP, USP and EP.
Related News: Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia.2-[1-(Mercaptomethyl)Cyclopropyl]Acetic Acid Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.N4-acetilcitosina CAS:14631-20-0 By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant’s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.93779-29-4 ICIG has agreed to offer employment to the unit’s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland.First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.